ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

9,769Medicare Part D Prescriptions Filled, Including Refills

Rank: 204 out of 2094

$759K Total Retail Price of All Prescriptions

Rank: 202 out of 2094

602 Patients Receiving at Least One Drug in Part D
91%Patients 65 Years and Older
45% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in New Jersey
Lower avg

Schedule Two
Controlled Substances

8% of this provider’s 602 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

10% of this provider’s 602 patients filled at least one prescription for a schedule three drug, compared to an average of 3%.

Risky Drugs to Seniors

1% of this provider’s 8,899 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

24% of this provider’s prescriptions were for brand-name drugs, compared to an average of 32%.

Prescription Price

$78 was the average price of a prescription from this provider, compared to $78 among peers.

Prescriptions per Patient

16 is the average number of prescriptions (including refills) per patient, compared to an average of 17.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in New Jersey
AMLODIPINE BESYLATE 413 384 1 2
OMEPRAZOLE 394 337 2 4
SIMVASTATIN 372 343 3 1
LEVOTHYROXINE SODIUM 278 256 4 3
FUROSEMIDE 234 220 5 6
LISINOPRIL 204 199 6 7
HYDROCHLOROTHIAZIDE 201 200 7 12
OXYCODONE-ACETAMINOPHEN 189 150 S2 8 40
METOPROLOL TARTRATE 168 147 9 10
HYDROCODONE-ACETAMINOPHEN 167 148 S3 10 42
ATORVASTATIN CALCIUM 153 141 11 5
ZOLPIDEM TARTRATE 152 141 12 14
CLONIDINE HCL 141 126 13 62
ATENOLOL 139 139 14 21
GLIMEPIRIDE 139 127 14 31
GABAPENTIN 131 122 16 23
DONEPEZIL HCL 120 120 17 20
LOVASTATIN 117 101 18 121
METOPROLOL SUCCINATE 110 104 19 9
DIOVAN 107 90 20 13
METFORMIN HCL 102 85 21 8
TRIAMTERENE-HCTZ 98 76 22 87
HYDRALAZINE HCL 97 85 23 89
CARVEDILOL 96 92 24 19
ENALAPRIL MALEATE 91 90 25 25
SERTRALINE HCL 90 89 26 26
TAMSULOSIN HCL 87 86 27 29
CITALOPRAM HBR 87 81 27 47
WARFARIN SODIUM 86 55 29 11
OXYCONTIN 86 70 S2 29 98
PRAVASTATIN SODIUM 84 84 31 18
CLOPIDOGREL 79 76 32 22
LOSARTAN POTASSIUM 70 69 33 17
ESCITALOPRAM OXALATE 67 63 34 46
CEFUROXIME 67 62 34 137
JANUVIA 66 61 36 35
TRAMADOL HCL 66 64 36 33
NEXIUM 65 63 38 16
CRESTOR 64 64 39 15
SYNTHROID 63 63 40 44
ACETAMINOPHEN-CODEINE 59 59 S3 41 129
FLUTICASONE PROPIONATE 58 57 42 41
PROAIR HFA 57 53 43 45
ZETIA 57 57 43 79
RAMIPRIL 55 51 45 48
PREDNISONE 55 54 45 54
DILTIAZEM 24HR ER 53 53 47 176
PANTOPRAZOLE SODIUM 53 53 47 37
LIPITOR 52 45 49 39
NAMENDA 51 51 50 32
MIRTAZAPINE 51 50 50 43
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on March 7, 2013.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.